Azithramycine

Azithramycine is a lipid of Polyketides (PK) class. Azithramycine is associated with abnormalities such as Respiratory Tract Infections, Pneumonia, Lower respiratory tract infection, Infection and Nonspecific urethritis. The involved functions are known as Lysis, Selection, Genetic, Mutation, Relapse and Adaptation. Azithramycine often locates in Blood, Respiratory System, Genitourinary system, Back and Chest. The associated genes with Azithramycine are Genes, rRNA, Genome, RPL22 gene, OPRM1 gene and tryptic soy broth. The related lipids are Liposomes, Phosphatidylserines, Promega, Lipopolysaccharides and Steroids. The related experimental models are Mouse Model, Knock-out and Tissue Model.

Cross Reference

Introduction

To understand associated biological information of Azithramycine, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Azithramycine?

Azithramycine is suspected in Infection, Pneumonia, Trachoma, Respiratory Tract Infections, Gonorrhea, Infectious disease of lung and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Azithramycine

MeSH term MeSH ID Detail
Urinary Tract Infections D014552 11 associated lipids
Urticaria D014581 13 associated lipids
Vertigo D014717 4 associated lipids
Vomiting D014839 21 associated lipids
Whooping Cough D014917 6 associated lipids
Wound Infection D014946 12 associated lipids
Yaws D015001 4 associated lipids
Superinfection D015163 3 associated lipids
Sexually Transmitted Diseases, Bacterial D015231 5 associated lipids
Mycobacterium avium-intracellulare Infection D015270 4 associated lipids
Dry Eye Syndromes D015352 10 associated lipids
Weight Gain D015430 101 associated lipids
Weight Loss D015431 56 associated lipids
Ethmoid Sinusitis D015521 2 associated lipids
Frontal Sinusitis D015522 1 associated lipids
Corneal Edema D015715 3 associated lipids
Erythema Chronicum Migrans D015787 3 associated lipids
Uveitis, Intermediate D015867 3 associated lipids
Lymphoma, B-Cell D016393 24 associated lipids
Helicobacter Infections D016481 21 associated lipids
Bronchial Hyperreactivity D016535 15 associated lipids
Purpura, Thrombocytopenic, Idiopathic D016553 4 associated lipids
Vaginosis, Bacterial D016585 10 associated lipids
Pneumocystis Infections D016720 1 associated lipids
Leishmaniasis, Cutaneous D016773 6 associated lipids
Malaria, Falciparum D016778 22 associated lipids
Ureaplasma Infections D016869 5 associated lipids
Neisseriaceae Infections D016870 3 associated lipids
Gram-Negative Bacterial Infections D016905 16 associated lipids
Common Variable Immunodeficiency D017074 4 associated lipids
AIDS-Related Opportunistic Infections D017088 9 associated lipids
Skin Diseases, Bacterial D017192 8 associated lipids
Pityriasis Rosea D017515 3 associated lipids
Aortic Aneurysm, Abdominal D017544 5 associated lipids
Pelvic Pain D017699 7 associated lipids
Community-Acquired Infections D017714 8 associated lipids
Granuloma, Pyogenic D017789 2 associated lipids
Furcation Defects D017823 1 associated lipids
T-Lymphocytopenia, Idiopathic CD4-Positive D018344 1 associated lipids
Pneumonia, Bacterial D018410 16 associated lipids
Parasitemia D018512 5 associated lipids
Abdominal Abscess D018784 2 associated lipids
Gingival Overgrowth D019214 7 associated lipids
Pseudolymphoma D019310 1 associated lipids
Pouchitis D019449 3 associated lipids
Syncope, Vasovagal D019462 1 associated lipids
Acquired Hyperostosis Syndrome D020083 1 associated lipids
Neurotoxicity Syndromes D020258 34 associated lipids
Focal Nodular Hyperplasia D020518 1 associated lipids
Multiple Sclerosis, Relapsing-Remitting D020529 7 associated lipids
Per page 10 20 50 100 | Total 276

PubChem Associated disorders and diseases

What pathways are associated with Azithramycine

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Azithramycine?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Azithramycine?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Azithramycine?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Azithramycine?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Azithramycine?

Mouse Model

Mouse Model are used in the study 'Azithromycin increases in vitro fibronectin production through interactions between macrophages and fibroblasts stimulated with Pseudomonas aeruginosa.' (Cory TJ et al., 2013), Mouse Model are used in the study 'Efficacy of azithromycin, clarithromycin and beta-lactam agents against experimentally induced bronchopneumonia caused by Haemophilus influenzae in mice.' (Miyazaki S et al., 2001), Mouse Model are used in the study 'Oral anti-pneumococcal activity and pharmacokinetic profiling of a novel peptide deformylase inhibitor.' (Gross M et al., 2004), Mouse Model are used in the study 'Inhibition of quorum sensing in Pseudomonas aeruginosa by azithromycin and its effectiveness in urinary tract infections.' (Bala A et al., 2011) and Mouse Model are used in the study 'Enhanced efficacy of single-dose versus multi-dose azithromycin regimens in preclinical infection models.' (Girard D et al., 2005).

Knock-out

Knock-out are used in the study 'Influence of rhlR and lasR on Polymyxin Pharmacodynamics in Pseudomonas aeruginosa and Implications for Quorum Sensing Inhibition with Azithromycin.' (Bulman ZP et al., 2017) and Knock-out are used in the study 'Azithromycin in Pseudomonas aeruginosa biofilms: bactericidal activity and selection of nfxB mutants.' (Mulet X et al., 2009).

Tissue Model

Tissue Model are used in the study 'Development of a population pharmacokinetic model characterizing the tissue distribution of azithromycin in healthy subjects.' (Zheng S et al., 2014).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Azithramycine

Download all related citations
Per page 10 20 50 100 | Total 4404
Authors Title Published Journal PubMed Link
Bergeron A et al. Azithromycin and Survival After Hematopoietic Stem Cell Transplant-Reply. 2017 JAMA pmid:29279924
Burr SE et al. Does azithromycin given to women in labour decrease ocular bacterial infection in neonates? A double-blind, randomized trial. 2017 BMC Infect. Dis. pmid:29282015
Last AR et al. The impact of a single round of community mass treatment with azithromycin on disease severity and ocular Chlamydia trachomatis load in treatment-naïve trachoma-endemic island communities in West Africa. 2017 Parasit Vectors pmid:29282126
Pavlinac PB et al. Azithromycin to prevent post-discharge morbidity and mortality in Kenyan children: a protocol for a randomised, double-blind, placebo-controlled trial (the Toto Bora trial). 2017 BMJ Open pmid:29289941
Bystrzycka W et al. Azithromycin and Chloramphenicol Diminish Neutrophil Extracellular Traps (NETs) Release. 2017 Int J Mol Sci pmid:29292737
Varano GP et al. Post-ischemic treatment with azithromycin protects ganglion cells against retinal ischemia/reperfusion injury in the rat. 2017 Mol. Vis. pmid:29296071
Sardana K et al. An observational study of the efficacy of azithromycin in erythema annulare centrifugum. 2018 Clin. Exp. Dermatol. pmid:29297941
Gibson PG How does azithromycin improve asthma exacerbations? - Author's reply. 2018 Lancet pmid:29323652
Crooks MG et al. How does azithromycin improve asthma exacerbations? 2018 Lancet pmid:29323653
Sarathchandran P et al. infection presenting as stroke and meningoencephalitis with aortic and subclavian aneurysms without pulmonary involvement. 2018 BMJ Case Rep pmid:29326371
Jenson A et al. Patient-centered communication of community treatment assistants in Tanzania predicts coverage of future mass drug administration for trachoma. 2018 Patient Educ Couns pmid:29329726
Buder S et al. Antimicrobial resistance of Neisseria gonorrhoeae in Germany: low levels of cephalosporin resistance, but high azithromycin resistance. 2018 BMC Infect. Dis. pmid:29343220
Jakubů V et al. Trends in the Minimum Inhibitory Concentrations of Erythromycin, Clarithromycin, Azithromycin, Ciprofloxacin, and Trimethoprim/Sulfamethoxazole for Strains of Bordetella pertussis isolated in the Czech Republic in 1967-2015. 2017 Cent. Eur. J. Public Health pmid:29346850
Huang S et al. Human babesiosis in Southeast China: A case report. 2018 Int. J. Infect. Dis. pmid:29355731
Morales A et al. Microbiological and clinical effects of probiotics and antibiotics on nonsurgical treatment of chronic periodontitis: a randomized placebo- controlled trial with 9-month follow-up. 2018 J Appl Oral Sci pmid:29364340
Yang D et al. The timing of azithromycin treatment is not associated with the clinical prognosis of childhood Mycoplasma pneumoniae pneumonia in high macrolide-resistant prevalence settings. 2018 PLoS ONE pmid:29377957
Ting CY and Shahdadpuri R Fuchs syndrome: a case of fever, mucositis and conjunctivitis. 2018 BMJ Case Rep pmid:29378740
Han B et al. Intrahepatic cholestasis of pregnancy or azithromycin-induced intrahepatic cholestasis: A case report. 2017 Medicine (Baltimore) pmid:29384912
Brereton CJ et al. Is gentamicin safe and effective for severe community-acquired pneumonia? An 8-year retrospective cohort study. 2018 Int. J. Antimicrob. Agents pmid:29410326
Mitjà O et al. Re-emergence of yaws after single mass azithromycin treatment followed by targeted treatment: a longitudinal study. 2018 Lancet pmid:29428183
Šmajs D and Pospíšilová P Macrolide resistance in yaws. 2018 Lancet pmid:29428184
Chen QF and Zhang YW [Clinical effect of Saccharomyces boulardii powder combined with azithromycin sequential therapy in treatment of children with diarrhea secondary to Mycoplasma pneumoniae pneumonia]. 2018 Zhongguo Dang Dai Er Ke Za Zhi pmid:29429459
Feng X and Liu J A combination of irsogladine maleate and azithromycin exhibits addictive protective effects in LPS-induced human gingival epithelial cells. 2017 Pharmazie pmid:29441859
Stieger N et al. Solution-mediated crystallization of amorphous azithromycin. 2017 Pharmazie pmid:29441902
Cai X et al. Anti-N-methyl-D-aspartate receptor encephalitis associated with acute Toxoplasma gondii infection: A case report. 2018 Medicine (Baltimore) pmid:29443773
Astale T et al. Population-based coverage survey results following the mass drug administration of azithromycin for the treatment of trachoma in Amhara, Ethiopia. 2018 PLoS Negl Trop Dis pmid:29451881
Marks M et al. Comparative efficacy of low-dose versus standard-dose azithromycin for patients with yaws: a randomised non-inferiority trial in Ghana and Papua New Guinea. 2018 Lancet Glob Health pmid:29456191
Mikalová L and Šmajs D Low-dose versus standard-dose azithromycin for treatment of yaws. 2018 Lancet Glob Health pmid:29456192
de Oliveira Alves A et al. Young Boy With Roughening in the Inner Eyelids. 2018 Ann Emerg Med pmid:29458812
Mannelli VK et al. . 2018 BMJ Case Rep pmid:29472421
Liu YH et al. Antimicrobial susceptibilities and molecular typing of neisseria gonorrhoeae isolates at a medical centre in Taiwan, 2001-2013 with an emphasis on high rate of azithromycin resistance among the isolates. 2018 Int. J. Antimicrob. Agents pmid:29477549
Atkin PA and Simms ML Orofacial granulomatosis: an unsuccessful response to weekly azithromycin pulse therapy. 2018 Oral Surg Oral Med Oral Pathol Oral Radiol pmid:29477603
Mulugeta A et al. Coverage, social mobilization and challenges of mass Zithromax administration campaign in South and South East zones of Tigray, Northern Ethiopia: A cross sectional study. 2018 PLoS Negl Trop Dis pmid:29481558
Bandyopadhyay R et al. Effectiveness of treatment regimens for Typhoid fever in the nalidixic acid-resistant S. typhi (NARST) era in South India. 2018 Trop Doct pmid:29495943
Kawamura K et al. Adjunctive therapy with azithromycin for moderate and severe acute respiratory distress syndrome: a retrospective, propensity score-matching analysis of prospectively collected data at a single center. 2018 Int. J. Antimicrob. Agents pmid:29501821
Xu L et al. Nursing care of a boy seriously infected with Steven-Johnson syndrome after treatment with azithromycin: A case report and literature review. 2018 Medicine (Baltimore) pmid:29505509
Agarwal P et al. susceptibility of Indian isolates to different antimalarial drugs & antibiotics. 2017 Indian J. Med. Res. pmid:29512604
Luo H et al. Clinical characteristics from co-infection with avian influenza A H7N9 and Mycoplasma pneumoniae: a case report. 2018 J Med Case Rep pmid:29540219
Kelly C et al. Macrolide antibiotics for bronchiectasis. 2018 Cochrane Database Syst Rev pmid:29543980
Azmanis P et al. First detection of Cryptosporidium parvum in falcons (Falconiformes): Diagnosis, molecular sequencing, therapeutic trial and epidemiological assessment of a possible emerging disease in captive falcons. 2018 Vet. Parasitol. pmid:29559142
Abdulai AA et al. Community-based mass treatment with azithromycin for the elimination of yaws in Ghana-Results of a pilot study. 2018 PLoS Negl Trop Dis pmid:29566044
Hong D et al. [Atopic keratoconjunctivitis: One allergy may mask another. A clinical observation with two types of hypersensitivity reactions: IgE-mediated and non-IgE-mediated]. 2018 J Fr Ophtalmol pmid:29567021
Pu Y et al. Azithromycin ameliorates OVA-induced airway remodeling in Balb/c mice via suppression of epithelial-to-mesenchymal transition. 2018 Int. Immunopharmacol. pmid:29567590
Rim JH et al. Recent Increase in the Incidence of TEM-135 β-Lactamase-harboring Neisseria gonorrhoeae in Korea. 2018 Ann Lab Med pmid:29611382
Li JG et al. [Eperythrozoonosis complicated with hemophagocytic syndrome: report of four cases and review of literature]. 2018 Zhonghua Er Ke Za Zhi pmid:29614573
Smith-Norowitz TA et al. Doxycycline suppresses Chlamydia pneumoniae induced interferon-gamma responses in peripheral blood mononuclear cells in children with allergic asthma. 2018 J. Infect. Chemother. pmid:29615379
Deguchi T et al. Macrolide and fluoroquinolone resistance is uncommon in clinical strains of Chlamydia trachomatis. 2018 J. Infect. Chemother. pmid:29627327
Ganesh R et al. Clinical profile and outcome of children with scrub typhus from Chennai, South India. 2018 Eur. J. Pediatr. pmid:29637374
Baker KS et al. Horizontal antimicrobial resistance transfer drives epidemics of multiple Shigella species. 2018 Nat Commun pmid:29654279
Barge L et al. Transient immune-mediated agranulocytosis following infection. 2018 BMJ Case Rep pmid:29669774
Wei W et al. MPEG-PCL Copolymeric Micelles for Encapsulation of Azithromycin. 2018 AAPS PharmSciTech pmid:29675667
Singh M et al. Sunray appearance in lacrimal canaliculitis. Indian J Pathol Microbiol pmid:29676385
Zmora N et al. Open label comparative trial of mono versus dual antibiotic therapy for Typhoid Fever in adults. 2018 PLoS Negl Trop Dis pmid:29684022
Keenan JD et al. Azithromycin to Reduce Childhood Mortality in Sub-Saharan Africa. 2018 N. Engl. J. Med. pmid:29694816
Weston EJ et al. Adherence to CDC Recommendations for the Treatment of Uncomplicated Gonorrhea - STD Surveillance Network, United States, 2016. 2018 MMWR Morb. Mortal. Wkly. Rep. pmid:29698384
Speer EM et al. Pentoxifylline, dexamethasone and azithromycin demonstrate distinct age-dependent and synergistic inhibition of TLR- and inflammasome-mediated cytokine production in human newborn and adult blood in vitro. 2018 PLoS ONE pmid:29715306
Naderi N et al. Long-term azithromycin therapy to reduce acute exacerbations in patients with severe chronic obstructive pulmonary disease. 2018 Respir Med pmid:29724384
Sharma P et al. Changing trends of culture-positive typhoid fever and antimicrobial susceptibility in a tertiary care North Indian Hospital over the last decade. Indian J Med Microbiol pmid:29735830
Williams PCM and Berkley JA Guidelines for the management of paediatric cholera infection: a systematic review of the evidence. 2018 Paediatr Int Child Health pmid:29790841
Saita MG et al. pH-Dependent stability of azithromycin in aqueous solution and structure identification of two new degradation products. 2018 J Pharm Biomed Anal pmid:29860178
Lam-Franco L et al. IL-1α and MMP-9 Tear Levels of Patients with Active Ocular Rosacea before and after Treatment with Systemic Azithromycin or Doxycycline. 2018 Ophthalmic Res. pmid:29874670
Lendermon EA et al. Azithromycin Fails to Prevent Accelerated Airway Obliteration in T-bet Mouse Lung Allograft Recipients. 2018 Transplant. Proc. pmid:29880387
Iguidbashian JP et al. and coinfection in the setting of ulcerative colitis. 2018 BMJ Case Rep pmid:29880626
Nüesch-Inderbinen M et al. Genetic characterization of Shiga toxin producing Escherichia coli belonging to the emerging hybrid pathotype O80:H2 isolated from humans 2010-2017 in Switzerland. 2018 Int. J. Med. Microbiol. pmid:29884331
Smotrys M et al. Babesiosis as a cause of false-positive HIV serology. 2018 BMJ Case Rep pmid:29884713
Ersoy B et al. The anti-inflammatory effects of erythromycin, clarithromycin, azithromycin and roxithromycin on histamine-induced otitis media with effusion in guinea pigs. 2018 J Laryngol Otol pmid:29888693
Kalua K et al. One round of azithromycin MDA adequate to interrupt transmission in districts with prevalence of trachomatous inflammation-follicular of 5.0-9.9%: Evidence from Malawi. 2018 PLoS Negl Trop Dis pmid:29897902
Lanz J and Lautenschlager S [CME Dermatology 16/Answer: Fever, Pustules and Joint Pain as Vacation Mementoes]. 2018 Praxis (Bern 1994) pmid:29921188
Valor C and Huber K Atypical presentation of cat scratch disease: Parinaud's oculoglandular syndrome with facial nerve paresis. 2018 BMJ Case Rep pmid:29982178
Al-Darraji A et al. Azithromycin therapy reduces cardiac inflammation and mitigates adverse cardiac remodeling after myocardial infarction: Potential therapeutic targets in ischemic heart disease. 2018 PLoS ONE pmid:30001416
Lederhandler MH et al. Severe Oral Mucositis: A Rare Adverse Event of Pembrolizumab. 2018 J Drugs Dermatol pmid:30005106
Celma A et al. Development of a Retention Time Interpolation scale (RTi) for liquid chromatography coupled to mass spectrometry in both positive and negative ionization modes. 2018 J Chromatogr A pmid:30005941
Zikic A et al. Treatment of Neonatal Chlamydial Conjunctivitis: A Systematic Review and Meta-analysis. 2018 J Pediatric Infect Dis Soc pmid:30007329
Lundin MS et al. Lemierre's syndrome and 2016 American College of Physician guidelines for pharyngitis: no to empiric coverage for bacterial pharyngitis. While no role for routine Fusobacterium PCR, keep suspicion for this pathogen. 2018 BMJ Case Rep pmid:30030249
Kamio K and Azuma A Diffuse panbronchiolitis: A fine road from the discovery of a disease to the establishment of treatment. 2018 Respir Investig pmid:30049592
Tilahun Z and Fenta TG Coverage of azithromycin mass treatment for trachoma elimination in Northwestern Ethiopia: a community based cross-sectional study. 2018 BMC Ophthalmol pmid:30081851
Montazeri M et al. Activities of anti-Toxoplasma drugs and compounds against tissue cysts in the last three decades (1987 to 2017), a systematic review. 2018 Parasitol. Res. pmid:30088074
Grewal TK et al. Therapeutic implications of nano-encapsulated rifabutin, azithromycin & ethambutol against experimental infection in mice. 2018 Indian J. Med. Res. pmid:30168492
Thapa A et al. Typhoid fever with isolated left lateral rectus palsy. 2018 BMJ Case Rep pmid:30181402
Sidhu H et al. Bioavailability of biosolids-borne ciprofloxacin and azithromycin to terrestrial organisms: Microbial toxicity and earthworm responses. 2019 Sci. Total Environ. pmid:30195128
Sidhu H et al. Retention-release of ciprofloxacin and azithromycin in biosolids and biosolids-amended soils. 2019 Sci. Total Environ. pmid:30196217
Hassan KS and Al-Khadouri G Pneumonia with Worsening Pleural Effusion Despite Treatment with Appropriate Antimicrobials: Case report. 2018 Sultan Qaboos Univ Med J pmid:30210860
Goyal V et al. Amoxicillin-clavulanate versus azithromycin for respiratory exacerbations in children with bronchiectasis (BEST-2): a multicentre, double-blind, non-inferiority, randomised controlled trial. 2018 Lancet pmid:30241722
El Sayed I et al. Antibiotics for treating scrub typhus. 2018 Cochrane Database Syst Rev pmid:30246875
Keenan JD et al. Azithromycin and Childhood Mortality in Africa. 2018 N. Engl. J. Med. pmid:30281987
Cutler T et al. Azithromycin and Childhood Mortality in Africa. 2018 N. Engl. J. Med. pmid:30284802
Michelow IC and Sánchez PJ Azithromycin and Childhood Mortality in Africa. 2018 N. Engl. J. Med. pmid:30284803
Obaro S Azithromycin and Childhood Mortality in Africa. 2018 N. Engl. J. Med. pmid:30284804
Lietman TM et al. Identifying a sufficient core group for trachoma transmission. 2018 PLoS Negl Trop Dis pmid:30296259
Sidhu H et al. Plant toxicity and accumulation of biosolids-borne ciprofloxacin and azithromycin. 2019 Sci. Total Environ. pmid:30340267
Walsh M et al. In vitro evaluation of CP-62,993, erythromycin, clindamycin, and tetracycline against Chlamydia trachomatis. 1987 Antimicrob. Agents Chemother. pmid:3038010
Sidhu H et al. Risk assessment of biosolids-borne ciprofloxacin and azithromycin. 2019 Sci. Total Environ. pmid:30463165
Tajima T et al. [Pharmacokinetic and clinical studies with azithromycin (fine granule) in the pediatric field. Pediatric Study Group of Azithromycin]. 1995 Jpn J Antibiot pmid:7474329
Fujii R et al. [Pharmacokinetic and clinical studies with azithromycin (capsule) in the pediatric field. Pediatric Study Group of Azithromycin]. 1995 Jpn J Antibiot pmid:7474330
Sasaki J et al. [Comparative clinical study of azithromycin with tosufloxacin tosilate in the treatment of acute odontogenic infection]. 1995 Jpn J Antibiot pmid:7474331
Uchino U et al. [Effects of azithromycin on fecal flora of healthy adult volunteers]. 1995 Jpn J Antibiot pmid:7474332
Toscano MA et al. [Efficacy and tolerance of azithromycin in respiratory tract infections in children]. 1995 Minerva Pediatr. pmid:7476752
Amland PF et al. A prospective, double-blind, placebo-controlled trial of a single dose of azithromycin on postoperative wound infections in plastic surgery. 1995 Plast. Reconstr. Surg. pmid:7480237
Scheen AJ [Pharma-clinics. Drug of the month. Azithromycin (Zitromax)]. 1995 Rev Med Liege pmid:7481274
Nahata MC et al. Pharmacokinetics of azithromycin in pediatric patients with acute otitis media. 1995 Antimicrob. Agents Chemother. pmid:7486938